209 related articles for article (PubMed ID: 2434288)
1. Biochemical effects of antidepressant treatment--studies of monoamine metabolites in cerebrospinal fluid and platelet [3H]imipramine binding.
Asberg M; Wägner A
Ciba Found Symp; 1986; 123():57-83. PubMed ID: 2434288
[TBL] [Abstract][Full Text] [Related]
2. Effects of clomipramine treatment on cerebrospinal fluid monoamine metabolites and platelet 3H-imipramine binding and serotonin uptake and concentration in major depressive disorder.
Mårtensson B; Wägner A; Beck O; Brodin K; Montero D; Asberg M
Acta Psychiatr Scand; 1991 Feb; 83(2):125-33. PubMed ID: 1708190
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid biogenic amine metabolites, plasma-rich platelet serotonin and [3H]imipramine reuptake in the primary fibromyalgia syndrome.
Legangneux E; Mora JJ; Spreux-Varoquaux O; Thorin I; Herrou M; Alvado G; Gomeni C
Rheumatology (Oxford); 2001 Mar; 40(3):290-6. PubMed ID: 11285376
[TBL] [Abstract][Full Text] [Related]
4. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
[TBL] [Abstract][Full Text] [Related]
5. Effects of amitriptyline and imipramine on brain amine neurotransmitter metabolites in cerebrospinal fluid.
Bowden CL; Koslow SH; Hanin I; Maas JW; Davis JM; Robins E
Clin Pharmacol Ther; 1985 Mar; 37(3):316-24. PubMed ID: 2578912
[TBL] [Abstract][Full Text] [Related]
6. Selective antidepressants and cerebrospinal fluid. Lack of specificity on norepinephrine and serotonin metabolites.
Potter WZ; Scheinin M; Golden RN; Rudorfer MV; Cowdry RW; Calil HM; Ross RJ; Linnoila M
Arch Gen Psychiatry; 1985 Dec; 42(12):1171-7. PubMed ID: 2416297
[TBL] [Abstract][Full Text] [Related]
7. Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
Sheline Y; Bardgett ME; Csernansky JG
J Clin Psychopharmacol; 1997 Feb; 17(1):11-4. PubMed ID: 9004051
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid monoamine metabolite concentrations in depressive disorder: A meta-analysis of historic evidence.
Ogawa S; Tsuchimine S; Kunugi H
J Psychiatr Res; 2018 Oct; 105():137-146. PubMed ID: 30219563
[TBL] [Abstract][Full Text] [Related]
9. Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldine.
Aberg-Wistedt A; Alvariza M; Bertilsson L; Malmgren R; Wachtmeister H
Acta Psychiatr Scand; 1985 Mar; 71(3):256-68. PubMed ID: 2580422
[TBL] [Abstract][Full Text] [Related]
10. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
11. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.
Engström G; Alling C; Blennow K; Regnéll G; Träskman-Bendz L
Eur Neuropsychopharmacol; 1999 Sep; 9(5):399-405. PubMed ID: 10523046
[TBL] [Abstract][Full Text] [Related]
12. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls.
Oreland L; Wiberg A; Asberg M; Träskman L; Sjöstrand L; Thorén P; Bertilsson L; Tybring G
Psychiatry Res; 1981 Feb; 4(1):21-9. PubMed ID: 6164071
[TBL] [Abstract][Full Text] [Related]
13. Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorder.
Wägner A; Aberg-Wistedt A; Asberg M; Bertilsson L; Mårtensson B; Montero D
Arch Gen Psychiatry; 1987 Oct; 44(10):870-7. PubMed ID: 2821953
[TBL] [Abstract][Full Text] [Related]
14. No major influence of regular tobacco smoking on cerebrospinal fluid monoamine metabolite concentrations in patients with psychotic disorder and healthy individuals.
Hjärpe J; Söderman E; Andreou D; Sedvall GC; Agartz I; Jönsson EG
Psychiatry Res; 2018 May; 263():30-34. PubMed ID: 29482043
[TBL] [Abstract][Full Text] [Related]
15. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder.
Sher L; Carballo JJ; Grunebaum MF; Burke AK; Zalsman G; Huang YY; Mann JJ; Oquendo MA
Bipolar Disord; 2006 Oct; 8(5 Pt 2):543-50. PubMed ID: 17042827
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid levels of monoamine metabolites in panic disorder.
Eriksson E; Westberg P; Alling C; Thuresson K; Modigh K
Psychiatry Res; 1991 Mar; 36(3):243-51. PubMed ID: 1712114
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of clorgyline on catecholamine and indoleamine metabolites in the cerebrospinal fluid of rhesus monkeys.
Garrick NA; Scheinin M; Chang WH; Linnoila M; Murphy DL
Biochem Pharmacol; 1984 May; 33(9):1423-7. PubMed ID: 6203542
[TBL] [Abstract][Full Text] [Related]
18. Increased concentrations of the monoamine metabolites homovanillic acid and 5-hydroxyindoleacetic acid in lumbar and central CSF and of 3-methoxy-4-hydroxyphenylglycol in lumbar CSF after subarachnoid haemorrhage.
von Holst H; Lindquist C; Sedvall G
Acta Neurochir (Wien); 1985; 77(3-4):146-51. PubMed ID: 2416192
[TBL] [Abstract][Full Text] [Related]
19. Changes of cerebrospinal fluid monoamine metabolites during long-term antidepressant treatment.
Bäckman J; Alling C; Alsén M; Regnéll G; Träskman-Bendz L
Eur Neuropsychopharmacol; 2000 Sep; 10(5):341-9. PubMed ID: 10974605
[TBL] [Abstract][Full Text] [Related]
20. Dystrobrevin-binding protein 1 gene (DTNBP1) variants associated with cerebrospinal fluid homovanillic acid and 5-hydroxyindoleacetic acid concentrations in healthy volunteers.
Andreou D; Saetre P; Kähler AK; Werge T; Andreassen OA; Agartz I; Sedvall GC; Hall H; Terenius L; Jönsson EG
Eur Neuropsychopharmacol; 2011 Sep; 21(9):700-4. PubMed ID: 21295953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
